LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 24.89 | 771.67 | 1399 | 2397 | 0.5835 | 0.4387 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 24.89 | 771.67 | 1376 | 2397 | 0.5739 | 0.4242 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 27.11 | 771.67 | 1449 | 2675 | 0.5417 | 0.4209 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 27.11 | 771.67 | 1433 | 2675 | 0.5357 | 0.4121 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 29.33 | 771.67 | 1374 | 2939 | 0.4675 | 0.3485 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 29.33 | 771.67 | 1334 | 2939 | 0.4538 | 0.3280 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 31.55 | 771.67 | 1329 | 3196 | 0.4157 | 0.3036 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 31.55 | 771.67 | 1367 | 3196 | 0.4276 | 0.3216 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 33.78 | 771.67 | 1332 | 3499 | 0.3806 | 0.2844 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 33.78 | 771.67 | 1330 | 3499 | 0.3800 | 0.2835 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 36.00 | 771.67 | 1311 | 3884 | 0.3375 | 0.2552 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 36.00 | 771.67 | 1483 | 3884 | 0.3818 | 0.3233 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 38.22 | 771.67 | 1409 | 4299 | 0.3277 | 0.2750 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 38.22 | 771.67 | 1460 | 4299 | 0.3396 | 0.2934 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 40.44 | 771.67 | 1341 | 4738 | 0.2830 | 0.2350 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 40.44 | 771.67 | 1302 | 4738 | 0.2748 | 0.2211 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 42.67 | 771.67 | 1391 | 5155 | 0.2698 | 0.2399 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 42.67 | 771.67 | 1341 | 5155 | 0.2601 | 0.2235 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 44.89 | 771.67 | 1339 | 5541 | 0.2416 | 0.2138 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 44.89 | 771.67 | 1351 | 5541 | 0.2438 | 0.2176 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 47.11 | 771.67 | 1417 | 5941 | 0.2385 | 0.2292 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 47.11 | 771.67 | 1379 | 5941 | 0.2321 | 0.2179 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 49.33 | 771.67 | 1398 | 6392 | 0.2187 | 0.2151 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 49.33 | 771.67 | 1422 | 6392 | 0.2224 | 0.2219 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 51.55 | 771.67 | 1368 | 6829 | 0.2003 | 0.1996 | MN20160304_L01 | L11 |